Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Prywatny Gabinet Internistyczno-Alergologiczny Zenon Siergiejko

Verified siteinfo

Poland ul. Ogrodowa 5, 15-010 Bialystok, Poland

  • 1 trial recruiting
  • Asthma · Chronic spontaneous urticaria · Cough
  • Adults and children

About Specializations

Prywatny Gabinet Internistyczno-Alergologiczny Zenon Siergiejko in Bialystok, Poland specialises in clinical trials of conditions such as Asthma, Chronic spontaneous urticaria, Cough, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Medicine

The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for chronic respiratory conditions. The ongoing research into Refractory or Unexplained Chronic Cough exemplifies the center's commitment to addressing complex respiratory challenges.

  • Chronic Cough Management
  • Advanced Inhalation Therapies
  • Respiratory Disease Mechanisms

By exploring novel therapeutic approaches, such as the use of inhalation powders, the center aims to improve patient outcomes and enhance the quality of life for those suffering from persistent cough conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Ogrodowa 515-010 BialystokPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified site

More sites in BialystokPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Chronic spontaneous urticaria

Recruiting

A study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Yuhan Corp.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Chronic spontaneous urticaria

Not recruiting

Study Comparing BP11 and Omalizumab for Patients with Chronic Spontaneous Urticaria Resistant to H1 Antihistamines

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Curateq Biologics Private Limited

Cough

Not recruiting

Study on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Nocion Therapeutics Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Teva Branded Pharmaceutical Products R&D LLC
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.